ALETTA 1.0 uses the validated EQ-5D questionnaire from the EuroQol Research Foundation. It is not a medical device and has no medical applications.
ALETTA 1.0 is a cloud-based real-world data management platform in which the validated EQ-5D questionnaire, a standardized instrument for recording general health status, is integrated. ALETTA is designed to be self-complete and therefore collects information directly from the patient using a mobile app available in the Android and Apple stores.
Use of ALETTA 1.0 to assess the quality of life of patients receiving MYCB1 cannabinoids:
“The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research.” Source: nap.edu
MYCB1 is in a continuous innovation to optimise patient adherence to medication. Most of our patients need to use the medication 2 to 4 times a day, and the bottle and syringe for oral application must be at hand during daily life activities. In addition, the medication must be protected from UV light and abrupt temperature changes.
The custom designed Travel Kit by MYCB1, is delivered for free to the patient with their first prescription; the thermal bag protects from UV light and temperature changes; and is user-friendly for the patient to carry and use the medication on the go.
ALETTA 1.0 is part of MYCB1 B.V. Apotheek, an ISO 27001:2017 and NEN 7510-1:2017 certified platform.
Protect the information used by the manufacturing of narcotic prescription products, internal communications, external communications with clients, the general public and collecting clinical data by a mobile app with the use of a Cloud Platform.
The Dutch security cluster ‘The Hague Security Delta’ is a network of businesses, governments and knowledge institutions, that work together on knowledge development and innovation in security. More info
MYCB1 products are serialised and ALETTA 1.0 uses counterfeiting protection technology.